Douglas Matthew Brown - Dec 30, 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Strategy Officer
Signature
/s/ Doug M Brown
Stock symbol
NEO
Transactions as of
Dec 30, 2021
Transactions value $
$0
Form type
4
Date filed
12/30/2021, 05:02 PM
Previous filing
Nov 26, 2021
Next filing
Mar 3, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +30.6K +262.56% $0.00 42.2K Dec 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 45K Dec 30, 2021 Common Stock 45K $28.33 Direct F2
holding NEO Stock Option (Right to Buy) 26.4K Dec 30, 2021 Common Stock 26.4K $53.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 30, 2021, Mr. Brown was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
F2 On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.